Zevra Therapeutics, Inc. · NASDAQ:ZVRA
Thompson Rahsaan sold 42,666 Zevra Therapeutics, Inc. shares (Form 4)
Traded Aug 14, 2026 · Filed Aug 17, 2026
On Aug 14, 2026, Thompson Rahsaan (Chief Legal & Compliance) sold 42,666 Zevra Therapeutics, Inc. shares at US$11.13 for US$475K under a trading plan, leaving 37,569 shares. Filed Aug 17, 2026 (Form 4).
- Sold
- 42,666 shares
- Price
- US$11.13
- Value
- US$475K
- Holding after
- 37,569 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Legal & Compliance
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 14, 2026 | Common Stock | Sale | 42,666 | US$11.13 | 37,569 | Direct |
Source
Related
- Zevra Therapeutics, Inc.
- Thompson Rahsaan
- Zevra Therapeutics, Inc. shareholders
- Form 4 · Thompson Rahsaan · Jun 23, 2026
- Form 4 · Thompson Rahsaan · May 13, 2026
- Form 4 · McFarlane Neil F. · Oct 13, 2026
- Schedule 13G/A · Woodline Partners LP · Aug 14, 2026
- Form 4 · Watton Corey Michael · Aug 12, 2026
- Schedule 13G/A · FMR LLC · Aug 6, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026